Insider Stock Trading History of Bock Louis C


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Bock Louis C since year 2005. The trader's CIK number is 1279735. At the time of this reporting, Bock Louis C is the Director of Orexigen Therapeutics, Inc. . (stock ticker symbol OREX). See this page for all insider trading activities at Orexigen Therapeutics, Inc. .

Note that in the past BOCK LOUIS C also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Bock Louis C since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2014-11-18 OREX Orexigen Therapeutics, Inc. Buy 1,325 5.58 7,392
2014-11-12 OREX Orexigen Therapeutics, Inc. Buy 27,052 5.56 150,544
2011-09-21 ZGNX Zogenix, Inc. Buy 1,250,000 2.00 2,500,000
2011-08-02 HZNP Horizon Pharma, Inc. Buy 315,946 9.00 2,843,514
2010-11-29 ZGNX Zogenix, Inc. Buy 1,839,645 4.00 7,358,580
2009-07-27 OREX Orexigen Therapeutics, Inc. Buy 300,000 7.50 2,250,000
2007-11-21 OREX Orexigen Therapeutics, Inc. Sale 100 15.00 1,500
2007-11-19 OREX Orexigen Therapeutics, Inc. Sale 2,200 15.07 33,147
2007-11-20 OREX Orexigen Therapeutics, Inc. Sale 600 15.00 9,000
2007-11-16 OREX Orexigen Therapeutics, Inc. Sale 30,419 15.71 477,791
2007-11-16 OREX Orexigen Therapeutics, Inc. Sale 16,142 15.51 250,313
2007-11-14 OREX Orexigen Therapeutics, Inc. Sale 518 15.99 8,282
2007-11-15 OREX Orexigen Therapeutics, Inc. Sale 14,295 15.51 221,729
2007-11-15 OREX Orexigen Therapeutics, Inc. Sale 14,206 15.65 222,323
2007-11-15 OREX Orexigen Therapeutics, Inc. Sale 1,499 15.51 23,252

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bock Louis C (Director of Orexigen Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.